TYPE 2 DIABETES AND ITS IMPACT ON THE IMMUNE SYSTEM

Authors

  • Nazarov.B.S Author
  • Ollomberganova M.Sh Author

Abstract

INTRODUCTION: Type 2 Diabetes (T2D) is a majorhealth problem worldwide. This metabolic disease is indicated by high blood glucose levels due to insufficient insulin production by the pancreas. An inflammatory response occurs as a result of the immune response to high blood glucose levels as well as the presence of inflammatory mediators produced by adipocytes and macrophages in fat tissue. This low and chronic inflammation damages the pancreatic beta cells and leads to insufficient insulin production, which results in hyperglycemia. Hyperglycemia in diabetes is thought to cause dysfunction of the immune response, which fails to control the spread of invading pathogens in diabetic subjects. Therefore, diabetic subjects are known to more susceptible to infections. The increased prevalence of T2D will increase the incidence of infectious diseases and related comorbidities.

Downloads

Download data is not yet available.

References

Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15(7): 539-53. [PubMed]

International Diabetes Federation. IDF Diabetes Atlas. 6th ed. 2013. [Google Scholar]

Zak K.P., Kondratskaya I.N., Melnichenko S.V., Popova V.V. The level of circulating IL-16 in the blood of patients with metabolic syndrome and type 2 diabetes mellitus. case. – 2007. – No. 5-6. – pp. 46-49.

Shagun O.V. Clinical and immunological aspects of diabetic nephropathy in patients with type 2 diabetes mellitus: abstract. dis. ... candidate of Medical Sciences: 14.00.05., 14.00.03 / Shagun Olga Vladimirovna; [Irkutsk State Medical University. university]. Irkutsk, 2007. – 20 p. – Bibliographer.: pp. 18-20.

Herder C., Baumert J., Thorand B. Elevated systemic chemokine concentrations precede the occurrence of coronary heart disease and type 2 diabetes: results from the MONICA/KORA Augsburg

study,1984-2002 // Diabetologia. – 2006. – 49 (Suppl). –

P. 695.

Belchenko, D.I. Investigation of autoregulation in

peripheral blood // Clinical laboratory diagnostics. -

– No. 3. – pp. 58-62.

Daoud A.K., Tayyar M.A., Fouda I.M., Harfeil N.A. Effects of diabetes

mellitus vs. in vitro hyperglycemia on select immune cell functions // J.

Immunotoxicol. – 2009. – No6(1). – pp. 36-41.

Downloads

Published

2024-05-06

Issue

Section

Articles